Breaking News, Promotions & Moves

DWK Life Sciences Names New Group CEO

After serving as CEO for 25 years, Armin Reiche hands operational responsibility to Michael Werth and joins the Advisory Board.

Author Image

By: Charlie Sternberg

Associate Editor

Armin Reiche and Michael Werth.

DWK Life Sciences, a global provider of precision glassware and primary packaging solutions for the life sciences industry, has announced Michael Werth as the new Group CEO.

Werth, who succeeds Armin Reiche after 25 years, brings extensive international leadership experience in technology and production-related businesses.

“After a quarter of a century at the helm of DWK Life Sciences, I am passing on leadership with full confidence in Michael Werth,” said outgoing Managing Director, Armin Reiche. “Our new CEO combines deep international management experience with strong operational expertise. I am convinced he will build on our track record of success – and bring exactly the right energy to position DWK for the future.”

Experience

Werth held senior roles at Heraeus Group for over a decade, including building and heading the company’s in-house consulting function. Most recently, he led the Heraeus Covantics business unit, focused on quartz and ceramic products for the semiconductor and optics industries. Prior to that, for many years, he held management positions at General Electric. As a certified Six Sigma Black Belt, he brings a data-driven approach to decision-making, and a strong track record of driving efficiency across the value chain.

“Continuity is the foundation of DWK Life Sciences’ decades-long success. I’m honored by the trust placed in me to carry that forward – while bringing fresh momentum to make the group more agile and customer-focused. What excites me most is the combination of global market strength and real relevance to science and pharma,” said Michael Werth.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters